Plasma levels of IL-37 and correlation with TNF-α, IL-17A, and disease activity during DMARD treatment of rheumatoid arthritis.
The aim of this study was to assess the change of IL-37 concentrations in rheumatoid arthritis (RA) patients under Disease-modifying anti-rheumatic drug (DMARD) therapy, and to establish a correlation between Interleukin-37 and pro-inflammatory cytokines in plasma and disease activity. The plasma le...
Main Authors: | Ping-Wei Zhao, Wei-Guang Jiang, Li Wang, Zhen-Yu Jiang, Yu-Xing Shan, Yan-Fang Jiang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4006923?pdf=render |
Similar Items
-
TNFα Promotes Th17 Cell Differentiation through IL-6 and IL-1β Produced by Monocytes in Rheumatoid Arthritis
by: Yingxia Zheng, et al.
Published: (2014-01-01) -
No effect of anti-TNF-α treatment on serum IL-17 in patients with rheumatoid arthritis
by: Dorota Sikorska, et al.
Published: (2018-10-01) -
Serum Level of TNF-α and IL-17 in Patient Have Chronic Periodontitis Associated Rheumatoid Arthritis
by: Munir Nasr Hamed, et al.
Published: (2017-03-01) -
IL-17A, IL-17RC polymorphisms and IL17 plasma levels in Tunisian patients with rheumatoid arthritis.
by: Tarak Dhaouadi, et al.
Published: (2018-01-01) -
Current and Emerging DMARDs for the Treatment of Rheumatoid Arthritis
by: Mysler E, et al.
Published: (2021-06-01)